tradingkey.logo
搜尋

Zimmer Biomet Holdings Inc

ZBH
添加自選
91.210USD
-1.890-2.03%
收盤 06/29, 16:00美東報價延遲15分鐘
17.83B總市值
23.59本益比TTM

Zimmer Biomet Holdings Inc

91.210
-1.890-2.03%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-2.03%

5天

+4.73%

1月

+10.79%

6月

+0.75%

今年開始到現在

+1.43%

1年

-0.27%

關鍵數據
92.880今開
92.880最高
1.91M成交量
23.59本益比TTM
10.28本益比動
0.960股利TTM
0.98%換手率
93.100昨收
91.110最低
78.56M成交額
19.73本益比靜
1.40市淨率
1.05%股息率 TTM
3.39%ROA
108.29052週最高
0.92量比
903.80M淨利潤
195.50M總股本
3.8671每股盈餘TTM
0.48Beta
6.07%ROE
79.12052週最低
1.90%振幅
64.62%毛利率
17.83B總市值
8.90回報/風險
1.47%風險率

TradingKey Zimmer Biomet Holdings Inc股票評分

單位: USD 更新時間: 2026-06-29

操作建議

Zimmer Biomet Holdings Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名17/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為98.87。中期看,股價處於平穩狀態。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Zimmer Biomet Holdings Inc評分

相關信息

行業排名
17 / 204
全市場排名
72 / 4570
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Zimmer Biomet Holdings Inc亮點

亮點風險
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
高分紅
公司屬於高分紅公司,最新股息支付率21.51%
估值合理
公司最新PE估值23.59,處於3年歷史合理位
羅伯特·奧爾斯坦持倉
明星投資者羅伯特·奧爾斯坦持倉,最新持倉95.32K股

分析師目標

基於 30 分析師
持有
評級
98.869
目標均價
+6.20%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Zimmer Biomet Holdings Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Zimmer Biomet Holdings Inc簡介

Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
公司代碼ZBH
公司Zimmer Biomet Holdings Inc
CEOTornos (Ivan)
網址https://www.zimmerbiomet.com/en

常見問題

Zimmer Biomet Holdings Inc(ZBH)的當前股價是多少?

Zimmer Biomet Holdings Inc(ZBH)的當前股價是 91.21。

Zimmer Biomet Holdings Inc 的股票代碼是什麼?

Zimmer Biomet Holdings Inc的股票代碼是ZBH。

Zimmer Biomet Holdings Inc股票的52週最高點是多少?

Zimmer Biomet Holdings Inc股票的52週最高點是108.29。

Zimmer Biomet Holdings Inc股票的52週最低點是多少?

Zimmer Biomet Holdings Inc股票的52週最低點是79.12。

Zimmer Biomet Holdings Inc的市值是多少?

Zimmer Biomet Holdings Inc的市值是17.83B。

現在Zimmer Biomet Holdings Inc(ZBH)的股票是買入、持有還是賣出?

根據分析師評級,Zimmer Biomet Holdings Inc(ZBH)的總體評級為signal_hold,目標價格為98.87。

Zimmer Biomet Holdings Inc(ZBH)股票的每股收益(EPS TTM)是多少

Zimmer Biomet Holdings Inc(ZBH)股票的每股收益(EPS TTM)是3.56。
KeyAI